Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 1139-1148

  Martín Subero, José Ignacio ^a   Gesk, Stefan ^a   Harder, Lana ^a   Grote, Werner ^a   Siebert, Reiner ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Hematological malignancies; Interphase FISH; WHO classification

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; B LYMPHOCYTE; BLOOD DISEASE; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; CYTOGENETICS; DIAGNOSTIC ACCURACY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOLLOW UP; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HEMATOLOGIC MALIGNANCY; HUMAN; INTERPHASE; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; RELIABILITY; T CELL LEUKEMIA; TUMOR CLASSIFICATION;

HEMATOLOGIC NEOPLASMS; HUMANS; INTERPHASE; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; WORLD HEALTH ORGANIZATION;

EID: 0037561652     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (67)

1. Harris NL, Jaffe ES, Vardiman JW, Stein H, Diebold J, Müller-Hermelink HK and Flandrin G: WHO classification of tumors of haematopoietic and lymphoid tissues: Introduction. In: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues (Jaffe ES, Harris NL, Stein H and Vardiman JW, eds). Lyon, IARC Press. 2001, pp 12-13.
2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Müller-Hermelink HK, Vardiman J, Lister TA and Bloomfield CD: The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 36: 69-86, 2000.
3. Brunning RD, Matutes E, Harris NL, Flandrin D, Vardiman J, Bennet J and Head D: Acute myeloid leukaemia: Introduction. In: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid ssues (Jaffe ES, Harris NL, Stein H and Vardiman JW, eds). Lyon, IARC Press. 2001, pp 77-80.
4. Harris NL: Mature B-cell neoplasms: Introduction. In: Pathology and Genetics of Tumors of Haematopoietic and Lympoid Tissues (Jaffe ES, Harris NL, Stein H and Vardiman JW, eds). Lyon, IARC Press. 2001, pp 121-126.
5. Jaffe ES: Hematopathology: integration of morphologic features and biologic markers for diagnosis. Mod Pathol 12: 109-115, 1999.
6. Chaganti RS, Nanjangud G, Schmidt H and Teruya-Feldstein J: Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. Semin Hematol 37: 396-411, 2000.
7. Ong ST and Le Beau MM: Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma. Semin Oncol 25: 447-460, 1998.
8. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372: 143-149, 1994.
9. Barr FG: Translocations, cancer and the puzzle of specificity. Nat Genet 19: 121-124, 1998.
10. Bernard OA and Berger R: Location and function of critical genes in leukemogenesis inferred from cytogenetic abnormalities in hematologic malignancies. Semin Hematol 37: 412-419, 2000.
11. Siebert R, Rosenwald A, Staudt LM and Morris SW: Molecular features of B-cell lymphoma. Curr Opin Oncol 13: 316-324, 2001.
12. Vogelstein B and Kinzler KW: The multistep nature of cancer. Trends Genet 9: 138-141, 1993.
13. Mitelman F: Recurrent chromosome aberrations in cancer. Mutat Res 462: 247-253, 2000.
14. Johansson B, Mertens F and Mitelman F: Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 86: 3905-3914, 1995.
15. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M and Bastard C: Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84: 1043-1049, 1994.
16. Harrison CJ and Secker-Walker LM: The importance of cytogenetics and associated molecular techniques in the management of patients with leukaemia. Clin Oncol (R Coll Radiol) 10: 255-261, 1998.
17. Mancini M, Cedrone M, Diverio D, Emanuel B, Stul M, Vranckx H, Brama M, De Cuia MR, Nanni M, Fazi F, Mecucci C, Alimena G and Hagemeijer A: Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients. Leukemia 14: 364-368, 2000.
18. Rowley JD: Cytogenetic analysis in leukemia and lymphoma: an introduction. Semin Hematol 37: 315-319, 2000.
19. Schlegelberger B, Metzke S, Harder S, Zühlke-Jenisch R, Zhang Y and Siebert R: Classical and molecular cytogenetics of tumor cells. In: Diagnostic Cytogenetics (Wegner R, ed). New York, Springer-Verlag. 1999, pp 151-185.
20. Bagg A and Kallakury BV: Molecular pathology of leukemia and lymphoma. Am J Clin Pathol 112: S76-92, 1999.
21. Drexler HG, Borkhardt A and Janssen JW: Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. Leuk Lymphoma 19: 359-380, 1995.
22. Dolken G, Illerhaus G, Hirt C and Mertelsmann R: BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with non-malignant diseases. J Clin Oncol 14: 1333-1344, 1996.
23. Maes B, Vanhentenrijk V, Wlodarska I, Cools J, Peeters B, Marynen P and de Wolf Peeters C: The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am J Pathol 158: 2185-2193, 2001.
24. Trümper L, Pfreundschuh M, Bonin FV and Daus H: Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals. Br J Haematol 103: 1138-1144, 1998.
25. Kearney L: The impact of the new fish technologies on the cytogenetics of haematological malignancies. Br J Haematol 104: 648-658, 1999.
26. Gozzetti A and Le Beau MM: Fluorescence in situ hybridization: uses and limitations. Semin Hematol 37: 320-333, 2000
27. Siebert R and Weber-Matthiesen K: Fluorescence in situ hybridization as a diagnostic tool in malignant lymphomas. Histochem Cell Biol 108: 391-402, 1997.
28. Speicher MR, Gwyn Ballard S and Ward DC: Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12: 368-375, 1996.
29. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y and Ried T: Multicolor spectral karyotyping of human chromosomes. Science 273: 494-497, 1996.
30. Schröck E and Padilla-Nash H: Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations. Semin Hematol 37: 334-347, 2000.
31. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992.
32. Lichter P, Joos S, Bentz M and Lampel S: Comparative genomic hybridization: uses and limitations. Semin Hematol 37: 348-357, 2000.
33. Viardot A, Martin-Subero JI, Siebert R, Harder S, Gesk S, Bentz M and Schlegelberger B: Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis. Leukemia 15: 177-183, 2001.
34. Barth TF, Benner A, Bentz M, Döhner H, Möller P and Lichter P: Risk of false positive results in comparative genomic hybridization. Genes Chromosomes Cancer 28: 353-357, 2000.
35. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Döhner H, Cremer T and Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407, 1997.
36. Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zühlke-Jenisch R, Metzke S, Joos S, Weber-Matthiesen K, Grote W and Schlegelberger B: Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14) (q24;q32) in B-cell lymphomas. Blood 91: 984-990, 1998.
37. Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zühlke-Jenisch R, Plendl H, Metzke S, Joos S, Zucca E, Weber-Matthiesen K, Roggero E, Grote W and Schlegelberger B: Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. Ann Oncol 9: 519-526, 1998.
38. Gesk S, Harder L, Grote W, Schlegelberger B and Siebert R: Evaluation of the commercially available interphase FISH probes LSI IGH/CCND1 and LSI IGH/BCL2 for the detection of t(11;14) and t(14;18) in malignant lymphomas. Ann Hematol 80 (Suppl 3): B137, 2001.
39. Taniwaki M, Nishida K, Ueda Y, Misawa S, Nagai M, Tagawa S, Yamagami T, Sugiyama H, Abe M and Fukuhara S. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization. Blood 85: 3223-3228, 1995.
40. Dierlamm J, Baens M, Stefanova-Ouzounova M, Hinz K, Wlodarska I, Maes B, Steyls A, Driessen A, Verhoef G, Gaulard P, Hagemeijer A, Hossfeld DK, De Wolf-Peeters C and Marynen P: Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using AP12 and MLT specific probes. Blood 96: 2215-2218, 2000.
41. Remstein ED, Kurtin PJ, Buno I, Bailey RJ, Proffitt J, Wyatt WA, Hanson CA and Dewald GW: Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol 110: 856-862, 2000.
42. Sanchez-Izquierdo D, Siebert R, Harder L, Marugan I, Gozzetti A, Price HP, Gesk S, Hernandez-Rivas JM, Benet I, Sole F, Sonoki T, Le Beau MM, Schlegelberger B, Dyer MJ, Garcia-Conde J and Martinez-Climent JA: Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia 15: 1475-1484, 2001.
43. Martin-Subero I, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent JA, Dyer MJS, Novo FJ, Calasanz MJ and Siebert R: Interphase FISH assays for the detection of translocations with breakpoints in inmunoglobulin light chain loci. Int J Cancer 98: 470-474, 2002.
44. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P and Döhner H: Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 83: 1922-1928, 1994.
45. Cook GP, Tomlinson IM, Walter G, Riethman H, Carter NP, Buluwela L, Winter G and Rabbitts TH: A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat Genet 7: 162-168, 1994.
46. Kahl C, Gesk S, Harder L, Harbott J, French L, Deloukas P, Grote W, Schlegelberger B and Siebert R: Detection of translocations involving the HOXII/TCL3-Locus in 10q24 by interphase-FISH. Cancer Genet Cytogenet 129: 80-84, 2001.
47. Jamil A, Theil KS, Kahwash S, Ruymann FB and Klopfenstein KJ: TEL/AML-1 fusion gene; its frequency and prognostic significance in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 122: 73-78, 2000.
48. Siebert R, Gesk S, Harder L, Steinemann D, Wlodarska I, Tiemann M, Schernmel V, Grote W and Schlegelberger B: Complex variant translocation t(1;2) with TPM3-ALK fusion due to cryptic ALK gene rearrangement in anaplastic large cell lymphoma. Blood 94: 3614-3617, 1999.
49. Kitsch IR and Ried T: Integration of cytogenetic data with genome maps and available probes: present status and future promise. Semin Hematol 37: 420-428, 2000.
50. Zhang Y, Matthiesen P, Harder S, Siebert R, Castoldi G, Calasanz MJ, Wong KF, Rosenwald A, Ott G, Atkin NB and Schlegelberger B: A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 27: 52-58, 2000.
51. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B and Morris SW: Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 22: 63-68, 1999.
52. Sonoki T, Harder L, Horsman DE, Karran EL, Taniguchi I, Willis TG, Gesk S, Steinemann D, Zucca E, Schlegelberger B, Sole F, Mungall AJ, Gascoyne RD, Siebert R and Dyer MJS: Cyclin D3 is a target gene of t(6;14)(p211;q32.3) of mature B-cell malignancies. Blood 98: 2837-2844, 2001.
53. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier; DG, Siebert R, Tucker PW and Dyer MJ: The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98: 3413-3420, 2001.
54. Dyer MJ, Lillington DM, Bastard C, Tilly H, Lens D, Heward JM, Stranks G, Morilla R, Monrad S, Guglielmi P, Kluin-Nelemans JC, Hagemeijer A, Young BD and Catovsky D: Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus. Leukemia 10: 1198-1208, 1996.
55. Sokolova IA, Hailing KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA and King W: The development of a multitarget, multicolor fluorescence-in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2: 116-123, 2000.
56. Fung J, Weier HU, Goldberg JD and Pedersen RA: Multilocus genetic analysis of single interphase cells by spectral imaging. Hum Genet 107: 615-622, 2000.
57. Henegariu O, Bray-Ward P, Artan S, Vance GH, Qumsyieh M and Ward DC: Small marker chromosome identification in metaphase and interphase using centromeric multiplex fish (cm-fish). Lab Invest 81: 475-481, 2001.
58. Martin-Subero JI, Gesk S, Harder L, Chudoba I, Luhmann B, Grote W, Novo FJ, Calasanz MJ and Siebert R: Multicolor interphase FISH for the detection of recurrent chromosomal translocations in lymphoid neoplasms. Onkologie 24 (Suppl 6): 100, 2001.
59. Weber-Matthiesen K, Winkemann M, Müller-Hermelink A, Schlegelberger B and Grote W: Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 40: 171-175, 1992.
60. Siebert R and Schlegelberger B: Combined immunophenotyping and interphase cytogenetics in malignant lymphomas: results from FICTION studies. Rev Clin Exp Hematol 4: 41-55, 1997.
61. Weber-Matthiesen K, Deerberg J, Poetsch M, Grote W and Schlegelberger B: Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 86: 1464-1468, 1995.
62. Martin-Subero JI, Gesk S, Harder L, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Tucker PW, Hansmann ML, Dyer MJS and Siebert R: Recurrent involvement of the REL and BCL I I A loci in classical Hodgkin's lymphoma. Blood 99: 1474-1477, 2002.
63. Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, Ohl S, Mechtersheimer G, Tramper L, Möller P, Lichter P and Barth TFE: Classical Hodgkin's lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99: 1381-1387, 2002.
64. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO and Staudt LM: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511, 2000.
65. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC and Golub TR: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine leaming. Nat Med 8: 68-74, 2002.
66. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO and Staudt LM: Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194: 1639-1647, 2001.
67. Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A and Dalla-Favera R: Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194: 1625-1638, 2001.